{
    "abstract": "Zorifertinib (AZD-3759; ZFB) is a potent, novel, oral, small molecule used for the treatment of non-small cell lung cancer (NSCLC). ZFB is Epidermal Growth Factor Receptor (EGFR) inhibitor that is characterized by good permeability of the blood-brain barrier for (NSCLC) patients with EGFR mutations. The present research reports the profiling of ",
    "authors": [
        {
            "affiliation": "Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University P.O. Box 2457 Riyadh 11451 Saudi Arabia mzeidan@ksu.edu.sa +966 1146 76 220 +966 1146 70237.",
            "firstname": "Nasser S",
            "initials": "NS",
            "lastname": "Al-Shakliah"
        },
        {
            "affiliation": "Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University P.O. Box 2457 Riyadh 11451 Saudi Arabia mzeidan@ksu.edu.sa +966 1146 76 220 +966 1146 70237.",
            "firstname": "Adnan A",
            "initials": "AA",
            "lastname": "Kadi"
        },
        {
            "affiliation": "Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University P.O. Box 2457 Riyadh 11451 Saudi Arabia mzeidan@ksu.edu.sa +966 1146 76 220 +966 1146 70237.",
            "firstname": "Haya I",
            "initials": "HI",
            "lastname": "Aljohar"
        },
        {
            "affiliation": "Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University P.O. Box 2457 Riyadh 11451 Saudi Arabia mzeidan@ksu.edu.sa +966 1146 76 220 +966 1146 70237.",
            "firstname": "Haitham",
            "initials": "H",
            "lastname": "AlRabiah"
        },
        {
            "affiliation": "Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University P.O. Box 2457 Riyadh 11451 Saudi Arabia mzeidan@ksu.edu.sa +966 1146 76 220 +966 1146 70237.",
            "firstname": "Mohamed W",
            "initials": "MW",
            "lastname": "Attwa"
        }
    ],
    "conclusions": null,
    "copyrights": "This journal is \u00a9 The Royal Society of Chemistry.",
    "doi": "10.1039/d2ra02848d\n10.1016/B978-0-12-387815-1.00002-2",
    "journal": "RSC advances",
    "keywords": [],
    "methods": null,
    "publication_date": "2022-08-04",
    "pubmed_id": "35919181\n18452692\n26622815\n26508876\n26000049\n24527320\n17827454\n27928026\n26313252\n35127465\n29056570\n18848531\n21702456\n19059358\n35123331\n21469730\n35540908\n29464466\n30471192\n35498318\n25742281\n27610414\n32158196\n30251155\n23045038\n30252204\n26673733\n15844510\n15236304\n30472584\n29086823\n30055343",
    "results": null,
    "title": "Profiling of ",
    "xml": "<Element 'PubmedArticle' at 0x788504c8b330>"
}